Perosphere Pharmaceuticals Inc, A Wholly Owned Subsidiary Of Amag Pharmaceuticals, Inc.

This Phase 2 study tested a drug called ciraparantag in 60 healthy adults aged 50 to 75 who were taking the blood thinner apixaban. The goal was to see if ciraparantag could quickly and safely reverse apixaban's blood-thinning effects, measured by clotting time. Participants rece…

This Phase 2 study tested a drug called ciraparantag in 69 healthy adults aged 50 to 75 who were given the blood thinner rivaroxaban. The goal was to see if ciraparantag could quickly reverse rivaroxaban's effects and restore normal clotting. Participants received either cirapara…